Skip to content
Delayed ~15 min

KLRA KAILERA THERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 8 analyst firms say about KAILERA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

12.97 USD+0.80 (+6.57%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+229.6%to the avg target 42.75 USD+29.78 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report30 Sep 2026avg report date 16 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8067
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8042

Recent analyst activity · last 90 days

Our tracked history has 3 reports on KLRA from 3 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Evercore ISIUmer RaffatBuy12 May 2026—
JefferiesRoger SongBuy12 May 202648.00 USD
JPMorganHardik ParikhBuy12 May 202630.00 USD
Leerink PartnersDavid RisingerBuy12 May 202636.00 USD
TD CowenYaron WerberBuy30 Sep 202657.00 USD
Weiss RatingsUnnamed analyst—21 Oct 2026—
William BlairAndy T HsiehBuy12 Aug 2026—
Data feed RESEARCHResearch TeamHold13 May 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:19 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.